We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Remdesivir treatment is associated with reduced ...

News that an experimental drug seems to be the first effective treatment for the new coronavirus has unleashed a flurry of interest - and a clamor to know how soon it might be available. Talk turned ...

Please provide your email address to receive an email when new articles are posted on . Remdesivir did not reduce adverse cardiovascular or kidney events in the study cohort. Remdesivir use was ...

Researchers released some good news about a possible treatment for coronavirus Wednesday -- evidence that the experimental drug remdesivir might help patients recover more quickly from the infection.

Excitement is building over remdesivir as a treatment for COVID-19. On Friday, the Food and Drug Administration authorized the emergency use of remdesivir to treat COVID-19, President Trump announced.

A 25% lower all-cause mortality is associated with timely initiation of remdesivir in immunocompromised patients hospitalized for COVID-19. Among patients with immunocompromising conditions who were ...

The US Food and Drug Administration approved remdesivir for the treatment of coronavirus infection, the drug's maker, Gilead Sciences, said Thursday. The drug, sold under the brand name Veklury, has ...

The maker of Remdesivir, an experimental drug for treatment of the coronavirus, is moving very quickly with the FDA for authorization to get the drug to patients, the CEO of the company, Gilead ...

Sign up for our Metro US email newsletter to get news, updates, and local insights delivered straight to your inbox! LONDON (Reuters) – Gilead’s remdesivir should ...

The FDA expanded remdesivir’s emergency use authorization to allow for all hospitalized COVID-19 patients, regardless of case severity, to be treated with the drug. The FDA granted emergency use ...

LONDON, Nov 20 (Reuters) - The European Commission on Friday said there had been no change in the authorised uses of Gilead's (GILD.O), opens new tab remdesivir after the World Health Organization ...